The interplay between anticancer challenges and the microbial communities from the gut Claire Amaris HobsonStéphane BonacorsiAndré Birgy Review 30 March 2022 Pages: 691 - 711
Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli Shunjin ZhaoYingjing WuJun Zhao Original Article 21 February 2022 Pages: 713 - 721
Evaluation of the VITEK2 AST-XN17 card for the detection of carbapenemase-producing Enterobacterales in isolates primarily producing metallo β-lactamase Tomokazu KuchibiroMasaru KomatsuIsao Nishi Original Article Open access 24 February 2022 Pages: 723 - 732
Validation of Rapid Antimicrobial Susceptibility Testing directly from blood cultures using WASPLab®, including Colibrí™ and Radian® in-Line Carousel Pauline Hilda HerroelenRobbe HeestermansAstrid Muyldermans Original Article Open access 25 February 2022 Pages: 733 - 739
Evaluating outcomes associated with revised fluoroquinolone breakpoints for Enterobacterales urinary tract infections: A retrospective cohort study Taylor M. BenavidesJames K. AdenStephanie E. Giancola Original Article 28 February 2022 Pages: 741 - 749
Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland Reetta SihvonenMaria TurunenAnu Pätäri-Sampo Original Article Open access 08 March 2022 Pages: 751 - 760
A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections Yusuf Mert DemirlenkLal Sude GücerÖnder Ergönül Original Article 18 March 2022 Pages: 761 - 769
Prosthetic joint infection diagnosis applying the three-level European Bone and Joint Infection Society (EBJIS) approach Chiara PapaliniGiacomo PucciMaria Bruna Pasticci Original Article Open access 22 March 2022 Pages: 771 - 778
Prevalence and clinical features of secondary skin lesions in septic patients with bloodstream infections Ana Pulido-PerezCarlos Sanchez-CarrilloEmilio Bouza Original Article 23 March 2022 Pages: 779 - 786
Gonococcal tysonitis, a rare local complication of gonorrhea: a clinical study of 15 cases Wenge FanQingsong ZhangTingwang Jiang Original Article 23 March 2022 Pages: 787 - 792
Laboratory and clinical predictors of focal involvement and bacteremia in brucellosis Betul CopurUgurcan Sayili Original Article 01 April 2022 Pages: 793 - 801
Non-structural protein 1 (NS1) variants from dengue virus clinical samples revealed mutations that influence NS1 production and secretion Anisa GhoshSoumi SuklaSubhajit Biswas Original Article 09 April 2022 Pages: 803 - 814
Rapid LC–MS/MS detection of different carbapenemase types in carbapenemase-producing Enterobacterales Gen LiZhihan YeLieying Fan Original Article 09 April 2022 Pages: 815 - 825
Incidence and risk factors for mortality in patients treated with combined ceftaroline for Gram-positive infective endocarditis D. Brandariz-NúñezJ. SuanzesI. Martín-Herranz Original Article 18 April 2022 Pages: 827 - 834
Transition to PCR diagnosis of cryptosporidiosis and giardiasis in the Norwegian healthcare system: could the increase in reported cases be due to higher sensitivity or a change in the testing algorithm? Sophie M. CampbellFrank O. PettersenLucy J. Robertson Brief Report Open access 04 March 2022 Pages: 835 - 839
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting Burcu IslerBerna ÖzerÖnder Ergönül Brief Report 17 March 2022 Pages: 841 - 847
Campylobacter infection in 4 patients treated with ibrutinib Boris SorinJulien VigneronMarion Malphettes Brief Report 18 March 2022 Pages: 849 - 852
Inoculum effect of Enterobacterales co-expressing OXA-48 and CTX-M on the susceptibility to ceftazidime/avibactam and meropenem A. MizrahiL. ChatB. Pilmis Brief Report 23 March 2022 Pages: 853 - 858
Characterization of hypervirulent Klebsiella pneumoniae isolates in Belgium Ahalieyah AnantharajahMatthieu DeltombeTe-Din Huang Brief Report 30 March 2022 Pages: 859 - 865
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020) Helio S. SaderMariana CastanheiraRodrigo M. Mendes Brief Report Open access 30 March 2022 Pages: 867 - 873